Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survivalCancer Immunol. Immunother. 2022 Oct 05;[EPub Ahead of Print], JS Weber, T Poretta, BD Stwalley, LA Sakkal, EX Du, T Wang, Y Chen, Y Wang, KA Betts, AN Shoushtari
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.